Cook Medical Reproductive Health business to be acquired for $875M

MedTech News: Cook Medical, a family-owned Australian business with international footprint, has signed a letter of intent to sell Cook’s Reproductive Health  business within the MedSurg division.  

Under the proposed transaction, CooperCompanies will pay $875 million for the acquisition. The company is a publicly held healthcare company focused on women’s health and fertility solutions, providing products and services in the Assisted Reproductive Technology (ART) journey.

For more than 40 years, Cook has had a focus on Reproductive Health, successfully developing products for obstetrics and gynaecology, In Vitro Fertilization (IVF) and ART.  Cook’s history with Reproductive Health is full of innovations that help patients fulfill their dreams of having a family, including developing the first needle specifically for IVF treatments. 

“Our history with reproductive health has been full of innovations to help patients fulfill their dreams of having a family,” said D.J. Sirota, senior vice president of Cook Medical’s MedSurg specialty. “This agreement represents more than a simple transaction; it is a commitment to offer a more complete range of solutions to customers and patients around the world. CooperSurgical is uniquely positioned to combine Cook’s reproductive health portfolio with their resources and plans to significantly invest in this product portfolio.”

You may also like: Gender equity essential for healthcare innovation, says J&J senior leader

William Cook Australia, Cook Spencer and Cook Vandergrift all currently manufacture reproductive health devices. After the closing of the transaction, Cook will continue to manufacture products for CooperSurgical during a two-year transition period and will increase manufacturing capacity to keep up with growth. No manufacturing jobs are at risk because of this partnership. Employees in manufacturing who support these products will continue to do so during the transition period and eventually will cross train to manufacture other Cook Medical products.  

“Like we always have been, we remain committed to the communities where we have facilities and employees, including Spencer, Vandergrift and Brisbane, where these products are manufactured,” said Pete Yonkman, president of Cook Medical and Cook Group.

“This agreement will allow us to invest in future growth and new technologies. The rest of the Cook organisation will continue as privately held, family-owned companies with no plans to change that status.”